StockMacro
Menu

Celanese

$45.01 -14% in 6 monthsMarket cap $4.9B

CE on XNYS, Materials, Celanese Corporation, job postings

Measures activity, not value. Not investment advice.

Quarterly revenue rose 5.7% to $2.6B while foreign specialist visa applications fell 76%.

  • GoodFree cash flow for 12 months reached $794M, against $262M net income
  • WatchDebt $11.6B against $1.4B cash on the balance sheet

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Celanese is a global specialty chemicals manufacturer. It operates in two segments: acetyl chain, and engineered materials. Acetyl chain profitability is exposed to commodity-linked raw materials and product pricing spreads. Engineered materials converts basic chemicals into higher-margin specialty polymers and compounds engineered for specific customer applications in automotive, medical, electronics, and industrial end markets.

Industry
Plastic material, synth resin/rubber, cellulos (no glass) (Materials)
Employees
11,434
Website
celanese.com
Listed
NYSE, US
Last results
2 Nov 2026
Next results
expected around 16 Feb 2027 (an estimate: a year ago it reported on 17 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $2.6B, net income $74.0M.
Quarter to 31 Dec 2021: revenue $2.3B, net income $524.0MQuarter to 31 Dec 2021: revenue $2.3B, net income $524.0MQuarter to 31 Mar 2022: revenue $2.5B, net income $502.0MQuarter to 31 Mar 2022: revenue $2.5B, net income $502.0MQuarter to 30 Jun 2022: revenue $2.5B, net income $434.0MQuarter to 30 Jun 2022: revenue $2.5B, net income $434.0MQuarter to 30 Sep 2022: revenue $2.3B, net income $191.0MQuarter to 30 Sep 2022: revenue $2.3B, net income $191.0MQuarter to 31 Dec 2022: revenue $2.3B, net income $767.0MQuarter to 31 Dec 2022: revenue $2.3B, net income $767.0MQuarter to 31 Mar 2023: revenue $2.9B, net income $91.0MQuarter to 31 Mar 2023: revenue $2.9B, net income $91.0MQuarter to 30 Jun 2023: revenue $2.8B, net income $220.0MQuarter to 30 Jun 2023: revenue $2.8B, net income $220.0MQuarter to 30 Sep 2023: revenue $2.7B, net income $951.0MQuarter to 30 Sep 2023: revenue $2.7B, net income $951.0MQuarter to 31 Dec 2023: revenue $2.6B, net income $698.0MQuarter to 31 Dec 2023: revenue $2.6B, net income $698.0MQuarter to 31 Mar 2024: revenue $2.6B, net income $121.0MQuarter to 31 Mar 2024: revenue $2.6B, net income $121.0MQuarter to 30 Jun 2024: revenue $2.7B, net income $155.0MQuarter to 30 Jun 2024: revenue $2.7B, net income $155.0MQuarter to 30 Sep 2024: revenue $2.6B, net income $116.0MQuarter to 30 Sep 2024: revenue $2.6B, net income $116.0MQuarter to 31 Dec 2024: revenue $2.4B, net income -$1.9BQuarter to 31 Dec 2024: revenue $2.4B, net income -$1.9BQuarter to 31 Mar 2025: revenue $2.4B, net income -$21.0MQuarter to 31 Mar 2025: revenue $2.4B, net income -$21.0MQuarter to 30 Jun 2025: revenue $2.5B, net income $199.0MQuarter to 30 Jun 2025: revenue $2.5B, net income $199.0MQuarter to 30 Sep 2025: revenue $2.4B, net income -$1.4BQuarter to 30 Sep 2025: revenue $2.4B, net income -$1.4BQuarter to 31 Dec 2025: revenue $2.2B, net income –Quarter to 31 Mar 2026: revenue $2.3B, net income $44.0MQuarter to 31 Mar 2026: revenue $2.3B, net income $44.0MQuarter to 30 Jun 2026: revenue $2.8B, net income $125.0MQuarter to 30 Jun 2026: revenue $2.8B, net income $125.0MQuarter to 30 Sep 2026: revenue $2.6B, net income $74.0MQuarter to 30 Sep 2026: revenue $2.6B, net income $74.0M
31 Dec 2021RevenueNet incomeNet losstallest bar $2.9B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$2.6B$74.0M
30 Jun 2026$2.8B$125.0M
31 Mar 2026$2.3B$44.0M
31 Dec 2025$2.2B–
30 Sep 2025$2.4B-$1.4B
30 Jun 2025$2.5B$199.0M
31 Mar 2025$2.4B-$21.0M
31 Dec 2024$2.4B-$1.9B
30 Sep 2024$2.6B$116.0M
30 Jun 2024$2.7B$155.0M
31 Mar 2024$2.6B$121.0M
31 Dec 2023$2.6B$698.0M
30 Sep 2023$2.7B$951.0M
30 Jun 2023$2.8B$220.0M
31 Mar 2023$2.9B$91.0M
31 Dec 2022$2.3B$767.0M
30 Sep 2022$2.3B$191.0M
30 Jun 2022$2.5B$434.0M
31 Mar 2022$2.5B$502.0M
31 Dec 2021$2.3B$524.0M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $9.8B $9.7B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +1.4% +8.9%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $262.0M -$3.1B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $2.37 -$28.32
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 20.8% 21.3% 26.6%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 7.9% -23.5% 7.4%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 2.7% -31.9% 4.3%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 6.4% 6.5%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $794.0M $1.0B
CashCash, cash equivalents and short-term investments on the latest balance sheet. $1.4B $1.4B
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $11.6B $12.9B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $10.3B $11.5B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 2.8 0.61
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $38.41
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 18.9 21.9
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.50 1.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.5 1.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.2 1.6

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
CelaneseCE (this company) $4.9B18.90.50+1.4%2.7%
Sensient TechnologySXT $4.8B28.62.8+9.5%9.7%
BalchemBCPC $5.2B30.44.7+9.4%15.4%
DPCDPC $4.6B––––
PerimeterPRM $4.5B81.35.4+31%6.7%
HexcelHXL $5.5B32.22.7+7.6%8.5%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-3.1%

437 13F filers vs 451

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

112.0M shares held by 13F filers (30 Sep 2026) of 109.8M outstanding (30 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

5.6%

6.1M shares sold short (30 Oct 2026) of 109.8M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.6

6.1M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+5.9%

5.8M shares sold short in the report before, 6.1M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

54%

54% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 52%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

-76%

4 vs 17 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+5.7%

$2.6B vs $2.4B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+7.8%

$69.0M vs $64.0M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$1.5M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

20

20 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

6.7×

20 articles in the last 7 days; its usual week has 3.

Price $45.01 on 20 Nov 2026, +27% over 12 months (12-month range $35.53 to $69.24)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $593K in the last 12 months (the 12 months before: $1.1M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 4 published in the last 12 months, -76% on the 12 months before.
Revenue per quarter. Revenue $2.6B in the latest quarter, +5.7% on a year earlier.
Capital spending per quarter. Capital spending $69.0M in the latest quarter, +7.8% on a year earlier.
Institutional holders (13F filers). 437 13F filers reported holding it in the latest 13F quarter, +12% on a year earlier.
Lobbying spend. Lobbying spend: $1.5M published in the last 12 months, +2.7% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
16 Nov 20268-K and other filingsElected Peter Matt as a director effective Nov 9, 2026; Board size increased from 11 to 12 members
16 Sep 20268-K and other filingsDirector or officer change
16 Sep 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Aug 2026Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 230K)
20 Apr 20268-K and other filingsDirector or officer change
4 Mar 20268-K and other filingsDirector or officer change
6 Jan 20268-K and other filingsDirector or officer change
6 Jan 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Oct 20258-K and other filingsRestructuring costs announced
19 Aug 2025Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 4 filing(s) in 30 days, value_usd total 306K)
11 Aug 20258-K and other filingsA major agreement ended
21 Apr 2025Sharp changeLobbying on a new issue: lobbying on a new issue: FOO (2025-03-31)
15 Apr 2025Sharp changeShort interest spike: short interest spike, 7.2M vs usual 5.1M (2025-03-31); 1.4x the same period a year earlier
1 Apr 2025Sharp changeShort interest spike: short interest spike, 8.6M vs usual 5.0M (2025-03-14); 1.7x the same period a year earlier
18 Mar 2025Sharp changeShort interest spike: short interest spike, 8.7M vs usual 5.0M (2025-02-28); 1.6x the same period a year earlier
11 Mar 2025Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 4 filing(s) in 30 days, value_usd total 644K)
14 Feb 20258-K and other filingsDirector or officer change
16 Jan 20258-K and other filingsDirector or officer change
19 Dec 20248-K and other filingsDirector or officer change
12 Dec 20248-K and other filingsDirector or officer change
9 Dec 20248-K and other filingsDirector or officer change
9 Dec 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Sep 20248-K and other filingsDirector or officer change
6 Sep 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Mar 20248-K and other filingsDirector or officer change
29 Feb 20248-K and other filingsRestructuring costs announced
28 Feb 20248-K and other filingsDirector or officer change
31 Jan 20248-K and other filingsDirector or officer change
4 Jan 2024Lobbying filinglobbying engagement terminated (CROWELL & MORING LLP)
6 Nov 20238-K and other filingsDirector or officer change
31 Oct 20238-K and other filingsRestructuring costs announced
18 Oct 20238-K and other filingsDirector or officer change
18 Oct 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Aug 2023Sharp changeShort interest spike: short interest spike, 5.6M vs usual 2.5M (2023-08-15); 2.7x the same period a year earlier
15 Aug 2023Sharp changeShort interest spike: short interest spike, 5.9M vs usual 2.3M (2023-07-31); 3.2x the same period a year earlier
1 Aug 2023Sharp changeShort interest spike: short interest spike, 5.1M vs usual 2.3M (2023-07-14); 2.9x the same period a year earlier
18 Jul 2023Sharp changeShort interest spike: short interest spike, 5.1M vs usual 2.2M (2023-06-30); 3.7x the same period a year earlier
4 Jul 2023Sharp changeShort interest spike: short interest spike, 5.0M vs usual 2.1M (2023-06-15); 2.7x the same period a year earlier
13 Jun 2023Sharp changeShort interest spike: short interest spike, 4.7M vs usual 2.1M (2023-05-31); 2.7x the same period a year earlier
30 May 2023Sharp changeShort interest spike: short interest spike, 4.4M vs usual 2.1M (2023-05-15); 2.2x the same period a year earlier
16 May 2023Sharp changeShort interest spike: short interest spike, 3.9M vs usual 2.0M (2023-04-28); 2.5x the same period a year earlier
2 May 2023Sharp changeShort interest spike: short interest spike, 4.1M vs usual 2.0M (2023-04-14); 2.6x the same period a year earlier
25 Apr 20238-K and other filingsDirector or officer change
18 Apr 2023Sharp changeShort interest spike: short interest spike, 3.5M vs usual 2.0M (2023-03-31); 2.2x the same period a year earlier
14 Feb 20238-K and other filingsDirector or officer change
14 Feb 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Jan 2023Sharp changeLobbying on a new issue: lobbying on a new issue: LBR (2022-12-31)
10 Nov 20228-K and other filingsDirector or officer change
10 Nov 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Nov 20228-K and other filingsCompleted an acquisition or asset sale
31 May 2022Sharp changeShort interest spike: short interest spike, 2.0M vs usual 1.2M (2022-05-13); 1.7x the same period a year earlier
29 Mar 2022Sharp changeShort interest spike: short interest spike, 2.1M vs usual 1.2M (2022-03-15); 1.3x the same period a year earlier
24 Mar 20228-K and other filingsA major agreement ended
28 Feb 20228-K and other filingsDirector or officer change
15 Feb 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 163.0M vs usual 97.0M (2021-12-31); 1.9x the same period a year earlier
9 Feb 20228-K and other filingsDirector or officer change
9 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Feb 2022Sharp changeLobbying spend jump: lobbying spend jump, 240K vs usual 80K (2021-12-31); 3.4x the same period a year earlier
4 Jan 2022Sharp changeWikipedia attention spike: wikipedia attention spike, 11K vs usual 932.50 (2021-12-27..2022-01-02); 16.5x the same week a year earlier
Insider net buying (open market)
Month from 1 Mar 2022: $255K published
Month from 1 Mar 2023: $141K published
Month from 1 May 2023: $317K published
Month from 1 Mar 2024: -$314K published
Month from 1 Aug 2024: -$1.2M published
Month from 1 Mar 2025: $698K published
Month from 1 May 2025: $77K published
Month from 1 Aug 2025: $306K published
Month from 1 Sep 2025: $48K published
Month from 1 Dec 2025: $363K published
Month from 1 Aug 2026: $230K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 3 published
Quarter from 1 Apr 2022: 3 published
Quarter from 1 Jul 2022: 1 published
Quarter from 1 Oct 2022: 3 published
Quarter from 1 Jan 2023: 2 published
Quarter from 1 Apr 2023: 4 published
Quarter from 1 Jul 2023: 2 published
Quarter from 1 Apr 2024: 4 published
Quarter from 1 Jul 2024: 10 published
Quarter from 1 Oct 2024: 2 published
Quarter from 1 Jan 2025: 4 published
Quarter from 1 Apr 2025: 3 published
Quarter from 1 Jul 2025: 5 published
Quarter from 1 Oct 2025: 5 published
Quarter from 1 Apr 2026: 3 published
Quarter from 1 Jul 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $2.3B, +43% on a year earlier; public on 11 Feb 2022
Quarter ended 31 Mar 2022: $2.5B, +41% on a year earlier; public on 30 Apr 2022
Quarter ended 30 Jun 2022: $2.5B, +13% on a year earlier; public on 30 Jul 2022
Quarter ended 30 Sep 2022: $2.3B, +1.5% on a year earlier; public on 5 Nov 2022
Quarter ended 31 Dec 2022: $2.3B, +3.2% on a year earlier; public on 25 Feb 2023
Quarter ended 31 Mar 2023: $2.9B, +12% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $2.8B, +12% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $2.7B, +18% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $2.6B, +9.4% on a year earlier; public on 24 Feb 2024
Quarter ended 31 Mar 2024: $2.6B, -8.5% on a year earlier; public on 11 May 2024
Quarter ended 30 Jun 2024: $2.7B, -5.2% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $2.6B, -2.8% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $2.4B, -7.7% on a year earlier; public on 22 Feb 2025
Quarter ended 31 Mar 2025: $2.4B, -8.5% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $2.5B, -4.5% on a year earlier; public on 12 Aug 2025
Quarter ended 30 Sep 2025: $2.4B, -8.6% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $2.2B, -7.0% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $2.3B, -2.2% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $2.8B, +8.7% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $2.6B, +5.7% on a year earlier; public on 4 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $163.0M, +92% on a year earlier; public on 11 Feb 2022
Quarter ended 31 Mar 2022: $137.0M, +49% on a year earlier; public on 30 Apr 2022
Quarter ended 30 Jun 2022: $124.0M, +13% on a year earlier; public on 30 Jul 2022
Quarter ended 30 Sep 2022: $139.0M, +36% on a year earlier; public on 5 Nov 2022
Quarter ended 31 Dec 2022: $143.0M, -12% on a year earlier; public on 25 Feb 2023
Quarter ended 31 Mar 2023: $164.0M, +20% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $145.0M, +17% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $131.0M, -5.8% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $128.0M, -10% on a year earlier; public on 24 Feb 2024
Quarter ended 31 Mar 2024: $137.0M, -16% on a year earlier; public on 11 May 2024
Quarter ended 30 Jun 2024: $105.0M, -28% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $88.0M, -33% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $105.0M, -18% on a year earlier; public on 22 Feb 2025
Quarter ended 31 Mar 2025: $102.0M, -26% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $93.0M, -11% on a year earlier; public on 12 Aug 2025
Quarter ended 30 Sep 2025: $64.0M, -27% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $84.0M, -20% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $66.0M, -35% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $62.0M, -33% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $69.0M, +7.8% on a year earlier; public on 4 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 622; public on 14 Feb 2022
31 Mar 2022 report: 637; public on 16 May 2022
30 Jun 2022 report: 613; public on 15 Aug 2022
30 Sep 2022 report: 564; public on 14 Nov 2022
31 Dec 2022 report: 588; public on 14 Feb 2023
31 Mar 2023 report: 598; public on 15 May 2023
30 Jun 2023 report: 578; public on 14 Aug 2023
30 Sep 2023 report: 559; public on 14 Nov 2023
31 Dec 2023 report: 595; public on 14 Feb 2024
31 Mar 2024 report: 635; public on 15 May 2024
30 Jun 2024 report: 624; public on 14 Aug 2024
30 Sep 2024 report: 579; public on 14 Nov 2024
31 Dec 2024 report: 543; public on 14 Feb 2025
31 Mar 2025 report: 436; public on 15 May 2025
30 Jun 2025 report: 426; public on 14 Aug 2025
30 Sep 2025 report: 391; public on 14 Nov 2025
31 Dec 2025 report: 394; public on 17 Feb 2026
31 Mar 2026 report: 457; public on 15 May 2026
30 Jun 2026 report: 451; public on 14 Aug 2026
30 Sep 2026 report: 437; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $240K published
Quarter from 1 Apr 2022: $1.1M published
Quarter from 1 Jul 2022: $270K published
Quarter from 1 Oct 2022: $270K published
Quarter from 1 Jan 2023: $260K published
Quarter from 1 Apr 2023: $500K published
Quarter from 1 Jul 2023: $250K published
Quarter from 1 Oct 2023: $320K published
Quarter from 1 Jan 2024: $380K published
Quarter from 1 Apr 2024: $340K published
Quarter from 1 Jul 2024: $240K published
Quarter from 1 Oct 2024: $420K published
Quarter from 1 Jan 2025: $370K published
Quarter from 1 Apr 2025: $490K published
Quarter from 1 Jul 2025: $320K published
Quarter from 1 Oct 2025: $310K published
Quarter from 1 Jan 2026: $300K published
Quarter from 1 Apr 2026: $440K published
Quarter from 1 Jul 2026: $460K published
Quarter from 1 Oct 2026: $330K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is workers named in WARN notices at 53 (21 Sep 2015), 44% below its normal reading of 94.
  • Clustered insider buying: had 3 insiders buy $230K of its shares on the open market within 30 days (3 filings) Public on 18 Aug 2026.
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 4 published in the last 12 months, -76% on the 12 months before.
  • Revenue per quarter: Revenue $2.6B in the latest quarter, +5.7% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 49 insider trades

No trades in the last 90 days; the latest was filed 17 Aug 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
17 Aug 2026Chuck KyrishSVP & CFOBuy2,300$45.52$105KForm 4
13 Aug 2026Ashley B DuffieSVP & GCBuy600$45.60$27KForm 4
12 Aug 2026Mark Christopher MurraySVP - AcetylsBuy2,153$45.52$98KForm 4
12 Dec 2025Scott A RichardsonCEO & PresidentBuy3,800$41.59$158KForm 4
11 Dec 2025Chuck KyrishSVP & CFOBuy5,000$41.03$205KForm 4
9 Sep 2025Timothy GoDirectorBuy1,039$46.25$48KForm 4
18 Aug 2025Ganesh MoorthyDirectorBuy1,000$40.94$41KForm 4
18 Aug 2025Scott McDougald SuttonDirectorBuy2,000$40.89$82KForm 4

437 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 58 opened a position, 72 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Dodge & Cox15.2M13.8%$673.9M-94K-0.6%
BlackRock, Inc.12.2M11.2%$543.3M-1.1M-8.4%
Vanguard Portfolio Management LLC6.6M6.06%$294.9M+121K+1.9%
Vanguard Capital Management LLC4.9M4.45%$216.7M-84K-1.7%
Dimensional Fund Advisors LP4.6M4.16%$202.4M+1.1M+31%
State Street Corp3.8M3.49%$170.1M-179K-4.5%
Capital Research Global Investors3.7M3.37%$164.2M-52K-1.4%
Fuller & Thaler Asset Management, Inc.3.5M3.16%$153.9M-50K-1.4%
Millennium Management LLC3.1M2.80%$136.1M+1.4M+88%
Federated Hermes, Inc.2.8M2.54%$123.5M+263K+10%

Company events

All 92 company events

In 12 months: 5 director or officer changes, 3 major agreements. Results releases and routine reports are left out.

FiledWhat happenedSource
16 Nov 2026Elected Peter Matt as a director effective Nov 9, 2026; Board size increased from 11 to 12 members8-K
16 Sep 2026Director or officer change8-K
4 Aug 2026Signed a major agreementSame filing: took on new debt8-K
20 Apr 2026Director or officer change8-K
4 Mar 2026Director or officer change8-K
6 Jan 2026Director or officer change8-K
17 Dec 2025Signed a major agreementSame filing: took on new debt8-K
4 Dec 2025Signed a major agreement8-K

Reported lobbying spend: $330K in Q3 2026, $460K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
31 Dec 2023EndedCrowell & Moring LLPfor Celanese CorporationNot statedFiling
1 Feb 2021NewHolland & Knight LLPfor Celanese CorporationChemical regulation.CHMFiling
1 Jul 2017NewCrowell & Moring LLPfor Celanese CorporationMiscellaneous Tariff Bill petitions for duty-free imports of certain high molecular weight polyethylene plasticsTARFiling
31 Dec 2013EndedSRG & Associatesfor Celanese CorpNot statedFiling
30 Jun 2013EndedFaegre Baker Daniels Consultingfor Celanese CorporationNot statedFiling
15 Nov 2010NewFaegre Baker Daniels Consultingfor Celanese CorporationChemical & Fuels PolicyEnergyFiling
31 Dec 2003EndedWinstead PCfor Celanese CorpTradeFiling
30 Jun 2003EndedNT Lakis, LLPfor Celanese CorpTradeFiling

Layoff notices

All 2 layoff notices

No notice in 12 months; the latest is dated 24 Sep 2015. State WARN notices.

NoticeSiteWorkersJobs endSource
24 Sep 2015CelaneseMorgan County, IL531 Dec 2015layoffNotice
31 Jan 2008CelaneseMorgan County, IL941 Mar 2008layoffNotice

The 5 newest of 195 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

18 Mar 2025confirmed

Confirmed across sources Insiders and Lobbying and Short interest and volume

Celanese (CE): had 4 insiders buy $644K of its shares on the open market within 30 days (4 filings); it also had 8.7M shares sold short in the 28 Feb 2025 report, 1.6× the same report last year; and it lobbying on a new issue. Three unrelated kinds of activity within 41 days.

  • Insiders: Clustered insider buying, became public on 11 Mar 2025
  • Short interest and volume: Short interest spike, became public on 12 Mar 2025
  • Short interest and volume: Short interest spike, became public on 26 Mar 2025
  • Short interest and volume: Short interest spike, became public on 10 Apr 2025
  • Lobbying: Lobbying on a new issue, became public on 21 Apr 2025
2024-02-29: 5.3M2024-03-15: 4.9M2024-03-28: 5.0M2024-04-15: 4.9M2024-04-30: 5.0M2024-05-15: 5.0M2024-05-31: 4.7M2024-06-14: 4.8M2024-06-28: 4.5M2024-07-15: 4.3M2024-07-31: 5.2M2024-08-15: 4.9M2024-08-30: 4.9M2024-09-13: 5.2M2024-09-30: 5.6M2024-10-15: 5.7M2024-10-31: 5.6M2024-11-15: 5.1M2024-11-29: 4.7M2024-12-13: 5.1M2024-12-31: 6.3M2025-01-15: 6.6M2025-01-31: 6.2M2025-02-14: 6.5M2025-02-28: 8.7M
The 28 Feb 2025 report against the 24 reports before it. this reportearliernormal: 5.0M
See the evidence (5 changes)

Insiders: Clustered insider buying became public on 11 Mar 2025

Celanese had 4 insiders buy $644K of its shares on the open market within 30 days (4 filings).

Independent buyers
4
Purchase filings (Form 4, code P)
4
Total bought
$644K
Window
9 Feb 2025 to 11 Mar 2025

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 12 Mar 2025

Celanese had 8.7M shares sold short in the 28 Feb 2025 report, 1.6× the same report last year.

This period
8.7M (the 28 Feb 2025 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
234K
How far from its usual level
+7.3
Same report last year
5.3M
History used
2,618 days
2024-02-29: 5.3M2024-03-15: 4.9M2024-03-28: 5.0M2024-04-15: 4.9M2024-04-30: 5.0M2024-05-15: 5.0M2024-05-31: 4.7M2024-06-14: 4.8M2024-06-28: 4.5M2024-07-15: 4.3M2024-07-31: 5.2M2024-08-15: 4.9M2024-08-30: 4.9M2024-09-13: 5.2M2024-09-30: 5.6M2024-10-15: 5.7M2024-10-31: 5.6M2024-11-15: 5.1M2024-11-29: 4.7M2024-12-13: 5.1M2024-12-31: 6.3M2025-01-15: 6.6M2025-01-31: 6.2M2025-02-14: 6.5M2025-02-28: 8.7M
the 28 Feb 2025 report24 earlier reportsnormal: 5.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Mar 2025

Celanese had 8.6M shares sold short in the 14 Mar 2025 report, 1.7× the same report last year.

This period
8.6M (the 14 Mar 2025 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
250K
How far from its usual level
+7.0
Same report last year
4.9M
History used
2,632 days
2024-03-15: 4.9M2024-03-28: 5.0M2024-04-15: 4.9M2024-04-30: 5.0M2024-05-15: 5.0M2024-05-31: 4.7M2024-06-14: 4.8M2024-06-28: 4.5M2024-07-15: 4.3M2024-07-31: 5.2M2024-08-15: 4.9M2024-08-30: 4.9M2024-09-13: 5.2M2024-09-30: 5.6M2024-10-15: 5.7M2024-10-31: 5.6M2024-11-15: 5.1M2024-11-29: 4.7M2024-12-13: 5.1M2024-12-31: 6.3M2025-01-15: 6.6M2025-01-31: 6.2M2025-02-14: 6.5M2025-02-28: 8.7M2025-03-14: 8.6M
the 14 Mar 2025 report24 earlier reportsnormal: 5.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Apr 2025

Celanese had 7.2M shares sold short in the 31 Mar 2025 report, 1.4× the same report last year.

This period
7.2M (the 31 Mar 2025 report)
Normal report (median of 24 earlier)
5.1M
Typical spread (median absolute deviation)
357K
How far from its usual level
+4.0
Same report last year
5.0M
History used
2,649 days
2024-03-28: 5.0M2024-04-15: 4.9M2024-04-30: 5.0M2024-05-15: 5.0M2024-05-31: 4.7M2024-06-14: 4.8M2024-06-28: 4.5M2024-07-15: 4.3M2024-07-31: 5.2M2024-08-15: 4.9M2024-08-30: 4.9M2024-09-13: 5.2M2024-09-30: 5.6M2024-10-15: 5.7M2024-10-31: 5.6M2024-11-15: 5.1M2024-11-29: 4.7M2024-12-13: 5.1M2024-12-31: 6.3M2025-01-15: 6.6M2025-01-31: 6.2M2025-02-14: 6.5M2025-02-28: 8.7M2025-03-14: 8.6M2025-03-31: 7.2M
the 31 Mar 2025 report24 earlier reportsnormal: 5.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Lobbying: Lobbying on a new issue became public on 21 Apr 2025

Celanese lobbying on a new issue.

New
['FOO']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12767750

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

15 Feb 2022confirmed

Confirmed across sources Filings + Financials and Lobbying

Celanese (CE): reported $240K of lobbying spend for the quarter ended 31 Dec 2021, 3.4× the same quarter last year, while it spent $163.0M on capital projects in the quarter ended 31 Dec 2021, 1.9× the same quarter last year. Two unrelated kinds of activity within 7 days.

  • Lobbying: Lobbying spend jump, became public on 8 Feb 2022
  • Financials: Quarterly capital spending jump, became public on 15 Feb 2022
2019-12-31: $70K2020-03-31: $461K2020-06-30: $60K2020-09-30: $90K2020-12-31: $70K2021-03-31: $610K2021-06-30: $70K2021-09-30: $160K2021-12-31: $240K
The quarter ended 31 Dec 2021 against the 8 quarters before it. this quarterearliernormal: $80K
See the evidence (2 changes)

Lobbying: Lobbying spend jump became public on 8 Feb 2022

Celanese reported $240K of lobbying spend for the quarter ended 31 Dec 2021, 3.4× the same quarter last year.

This period
$240K (the quarter ended 31 Dec 2021)
Normal quarter (median of 8 earlier)
$80K
Typical spread (median absolute deviation)
$15K
How far from its usual level
+7.2
Same quarter last year
$70K
History used
4,293 days
2019-12-31: $70K2020-03-31: $461K2020-06-30: $60K2020-09-30: $90K2020-12-31: $70K2021-03-31: $610K2021-06-30: $70K2021-09-30: $160K2021-12-31: $240K
the quarter ended 31 Dec 20218 earlier quartersnormal: $80K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Financials: Quarterly capital spending jump became public on 15 Feb 2022

Celanese spent $163.0M on capital projects in the quarter ended 31 Dec 2021, 1.9× the same quarter last year.

This period
$163.0M (the quarter ended 31 Dec 2021)
Normal quarter (median of 8 earlier)
$97.0M
Typical spread (median absolute deviation)
$12.5M
How far from its usual level
+3.6
Same quarter last year
$85.0M
History used
4,840 days
2019-12-31: $144.0M2020-03-31: $119.0M2020-06-30: $88.0M2020-09-30: $72.0M2020-12-31: $85.0M2021-03-31: $92.0M2021-06-30: $110.0M2021-09-30: $102.0M2021-12-31: $163.0M
the quarter ended 31 Dec 20218 earlier quartersnormal: $97.0M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

Check it at the source: SEC EDGAR quarterly reports.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

26 Oct 2021confirmed

Confirmed across sources Filings + Financials and Lobbying

Celanese (CE): reported revenue of $2.3B for the quarter ended 30 Sep 2021, 1.6× the same quarter last year, while it reported $160K of lobbying spend for the quarter ended 30 Sep 2021, 1.8× the same quarter last year. Two unrelated kinds of activity on the same day.

  • Financials: Quarterly revenue change, became public on 26 Oct 2021
  • Lobbying: Lobbying spend jump, became public on 21 Oct 2021
2019-09-30: $1.6B2019-12-31: $1.4B2020-03-31: $1.5B2020-06-30: $1.2B2020-09-30: $1.4B2020-12-31: $1.6B2021-03-31: $1.8B2021-06-30: $2.2B2021-09-30: $2.3B
The quarter ended 30 Sep 2021 against the 8 quarters before it. this quarterearliernormal: $1.5B
See the evidence (2 changes)

Financials: Quarterly revenue change became public on 26 Oct 2021

Celanese reported revenue of $2.3B for the quarter ended 30 Sep 2021, 1.6× the same quarter last year.

This period
$2.3B (the quarter ended 30 Sep 2021)
Normal quarter (median of 8 earlier)
$1.5B
Typical spread (median absolute deviation)
$101.5M
How far from its usual level
+4.9
Same quarter last year
$1.4B
History used
4,840 days
2019-09-30: $1.6B2019-12-31: $1.4B2020-03-31: $1.5B2020-06-30: $1.2B2020-09-30: $1.4B2020-12-31: $1.6B2021-03-31: $1.8B2021-06-30: $2.2B2021-09-30: $2.3B
the quarter ended 30 Sep 20218 earlier quartersnormal: $1.5B

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Lobbying: Lobbying spend jump became public on 21 Oct 2021

Celanese reported $160K of lobbying spend for the quarter ended 30 Sep 2021, 1.8× the same quarter last year.

This period
$160K (the quarter ended 30 Sep 2021)
Normal quarter (median of 8 earlier)
$75K
Typical spread (median absolute deviation)
$10K
How far from its usual level
+4.2
Same quarter last year
$90K
History used
4,110 days
2019-09-30: $80K2019-12-31: $70K2020-03-31: $461K2020-06-30: $60K2020-09-30: $90K2020-12-31: $70K2021-03-31: $610K2021-06-30: $70K2021-09-30: $160K
the quarter ended 30 Sep 20218 earlier quartersnormal: $75K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 16 Nov 2026Filings record

    Elected Peter Matt as a director effective Nov 9, 2026; Board size increased from 11 to 12 members

  2. 16 Sep 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 16 Sep 2026Filings record

    Director or officer change

  4. 18 Aug 2026Insiders change

    had 3 insiders buy $230K of its shares on the open market within 30 days (3 filings).

    Who bought: Murray Mark Christopher, Duffie Ashley B, Kyrish Chuck.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $230K
    Window
    19 Jul 2026 to 18 Aug 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  5. 18 Aug 2026Insiders record

    Kyrish Chuck (SVP & CFO) bought 2,300 shares of CE ($104,701) (dated 17 Aug 2026)

  6. 14 Aug 2026Insiders record

    Duffie Ashley B (SVP & GC) bought 600 shares of CE ($27,360) (dated 13 Aug 2026)

  7. 13 Aug 2026Insiders record

    Murray Mark Christopher (SVP - Acetyls) bought 2,153 shares of CE ($98,005) (dated 12 Aug 2026)

  8. 20 Apr 2026Filings record

    Director or officer change

  9. 4 Mar 2026Filings record

    Director or officer change

  10. 6 Jan 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  11. 6 Jan 2026Filings record

    Director or officer change

  12. 13 Dec 2025Insiders record

    Richardson Scott A (CEO & President) bought 3,800 shares of CE ($158,042) (dated 12 Dec 2025)

  13. 12 Dec 2025Insiders record

    Kyrish Chuck (SVP & CFO) bought 5,000 shares of CE ($205,150) (dated 11 Dec 2025)

  14. 28 Oct 2025Filings record

    Restructuring costs announced

  15. 10 Sep 2025Insiders record

    Go Timothy (director) bought 1,039 shares of CE ($48,056) (dated 9 Sep 2025)

  16. 19 Aug 2025Insiders change

    had 4 insiders buy $306K of its shares on the open market within 30 days (4 filings).

    Who bought: Galante Edward G, Murray Mark Christopher, Sutton Scott McDougald, Moorthy Ganesh.

    See the evidence (4 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $306K
    Window
    20 Jul 2025 to 19 Aug 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  17. 19 Aug 2025Insiders record

    MOORTHY GANESH (director) bought 1,000 shares of CE ($40,940) (dated 18 Aug 2025)

  18. 19 Aug 2025Insiders record

    Sutton Scott McDougald (director) bought 2,000 shares of CE ($81,780) (dated 18 Aug 2025)

  19. 19 Aug 2025Insiders record

    Murray Mark Christopher (SVP - Acetyls) bought 2,017 shares of CE ($84,371) (dated 18 Aug 2025)

  20. 19 Aug 2025Insiders record

    GALANTE EDWARD G (director) bought 2,400 shares of CE ($99,048) (dated 18 Aug 2025)

  21. 11 Aug 2025Filings record

    A major agreement ended

  22. 29 May 2025Insiders record

    Murray Mark Christopher (SVP - Acetyls) bought 1,479 shares of CE ($77,174) (dated 28 May 2025)

  23. 21 Apr 2025Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['FOO']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12767750
  24. 10 Apr 2025Short interest and volume change

    had 7.2M shares sold short in the 31 Mar 2025 report, 1.4× the same report last year.

    Same report last year: 5.0M; its normal report is 5.1M.

    See the evidence
    This period
    7.2M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    5.1M
    Typical spread (median absolute deviation)
    357K
    How far from its usual level
    +4.0
    Same report last year
    5.0M
    History used
    2,649 days
    2024-03-28: 5.0M2024-04-15: 4.9M2024-04-30: 5.0M2024-05-15: 5.0M2024-05-31: 4.7M2024-06-14: 4.8M2024-06-28: 4.5M2024-07-15: 4.3M2024-07-31: 5.2M2024-08-15: 4.9M2024-08-30: 4.9M2024-09-13: 5.2M2024-09-30: 5.6M2024-10-15: 5.7M2024-10-31: 5.6M2024-11-15: 5.1M2024-11-29: 4.7M2024-12-13: 5.1M2024-12-31: 6.3M2025-01-15: 6.6M2025-01-31: 6.2M2025-02-14: 6.5M2025-02-28: 8.7M2025-03-14: 8.6M2025-03-31: 7.2M
    the 31 Mar 2025 report24 earlier reportsnormal: 5.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 26 Mar 2025Short interest and volume change

    had 8.6M shares sold short in the 14 Mar 2025 report, 1.7× the same report last year.

    Same report last year: 4.9M; its normal report is 5.0M.

    See the evidence
    This period
    8.6M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    250K
    How far from its usual level
    +7.0
    Same report last year
    4.9M
    History used
    2,632 days
    2024-03-15: 4.9M2024-03-28: 5.0M2024-04-15: 4.9M2024-04-30: 5.0M2024-05-15: 5.0M2024-05-31: 4.7M2024-06-14: 4.8M2024-06-28: 4.5M2024-07-15: 4.3M2024-07-31: 5.2M2024-08-15: 4.9M2024-08-30: 4.9M2024-09-13: 5.2M2024-09-30: 5.6M2024-10-15: 5.7M2024-10-31: 5.6M2024-11-15: 5.1M2024-11-29: 4.7M2024-12-13: 5.1M2024-12-31: 6.3M2025-01-15: 6.6M2025-01-31: 6.2M2025-02-14: 6.5M2025-02-28: 8.7M2025-03-14: 8.6M
    the 14 Mar 2025 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 18 Mar 2025several at once

    had 4 insiders buy $644K of its shares on the open market within 30 days (4 filings); it also had 8.7M shares sold short in the 28 Feb 2025 report, 1.6× the same report last year; and it lobbying on a new issue. Three unrelated kinds of activity within 41 days.

    See the evidence (5 changes)

    Insiders: Clustered insider buying became public on 11 Mar 2025

    Celanese had 4 insiders buy $644K of its shares on the open market within 30 days (4 filings).

    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $644K
    Window
    9 Feb 2025 to 11 Mar 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Short interest and volume: Short interest spike became public on 12 Mar 2025

    Celanese had 8.7M shares sold short in the 28 Feb 2025 report, 1.6× the same report last year.

    This period
    8.7M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    234K
    How far from its usual level
    +7.3
    Same report last year
    5.3M
    History used
    2,618 days
    2024-02-29: 5.3M2024-03-15: 4.9M2024-03-28: 5.0M2024-04-15: 4.9M2024-04-30: 5.0M2024-05-15: 5.0M2024-05-31: 4.7M2024-06-14: 4.8M2024-06-28: 4.5M2024-07-15: 4.3M2024-07-31: 5.2M2024-08-15: 4.9M2024-08-30: 4.9M2024-09-13: 5.2M2024-09-30: 5.6M2024-10-15: 5.7M2024-10-31: 5.6M2024-11-15: 5.1M2024-11-29: 4.7M2024-12-13: 5.1M2024-12-31: 6.3M2025-01-15: 6.6M2025-01-31: 6.2M2025-02-14: 6.5M2025-02-28: 8.7M
    the 28 Feb 2025 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Mar 2025

    Celanese had 8.6M shares sold short in the 14 Mar 2025 report, 1.7× the same report last year.

    This period
    8.6M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    250K
    How far from its usual level
    +7.0
    Same report last year
    4.9M
    History used
    2,632 days
    2024-03-15: 4.9M2024-03-28: 5.0M2024-04-15: 4.9M2024-04-30: 5.0M2024-05-15: 5.0M2024-05-31: 4.7M2024-06-14: 4.8M2024-06-28: 4.5M2024-07-15: 4.3M2024-07-31: 5.2M2024-08-15: 4.9M2024-08-30: 4.9M2024-09-13: 5.2M2024-09-30: 5.6M2024-10-15: 5.7M2024-10-31: 5.6M2024-11-15: 5.1M2024-11-29: 4.7M2024-12-13: 5.1M2024-12-31: 6.3M2025-01-15: 6.6M2025-01-31: 6.2M2025-02-14: 6.5M2025-02-28: 8.7M2025-03-14: 8.6M
    the 14 Mar 2025 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Apr 2025

    Celanese had 7.2M shares sold short in the 31 Mar 2025 report, 1.4× the same report last year.

    This period
    7.2M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    5.1M
    Typical spread (median absolute deviation)
    357K
    How far from its usual level
    +4.0
    Same report last year
    5.0M
    History used
    2,649 days
    2024-03-28: 5.0M2024-04-15: 4.9M2024-04-30: 5.0M2024-05-15: 5.0M2024-05-31: 4.7M2024-06-14: 4.8M2024-06-28: 4.5M2024-07-15: 4.3M2024-07-31: 5.2M2024-08-15: 4.9M2024-08-30: 4.9M2024-09-13: 5.2M2024-09-30: 5.6M2024-10-15: 5.7M2024-10-31: 5.6M2024-11-15: 5.1M2024-11-29: 4.7M2024-12-13: 5.1M2024-12-31: 6.3M2025-01-15: 6.6M2025-01-31: 6.2M2025-02-14: 6.5M2025-02-28: 8.7M2025-03-14: 8.6M2025-03-31: 7.2M
    the 31 Mar 2025 report24 earlier reportsnormal: 5.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Lobbying: Lobbying on a new issue became public on 21 Apr 2025

    Celanese lobbying on a new issue.

    New
    ['FOO']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12767750

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  27. 14 Mar 2025Insiders record

    MOORTHY GANESH (director) bought 1,000 shares of CE ($53,290) (dated 13 Mar 2025)

  28. 12 Mar 2025Short interest and volume change

    had 8.7M shares sold short in the 28 Feb 2025 report, 1.6× the same report last year.

    Same report last year: 5.3M; its normal report is 5.0M.

    See the evidence
    This period
    8.7M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    234K
    How far from its usual level
    +7.3
    Same report last year
    5.3M
    History used
    2,618 days
    2024-02-29: 5.3M2024-03-15: 4.9M2024-03-28: 5.0M2024-04-15: 4.9M2024-04-30: 5.0M2024-05-15: 5.0M2024-05-31: 4.7M2024-06-14: 4.8M2024-06-28: 4.5M2024-07-15: 4.3M2024-07-31: 5.2M2024-08-15: 4.9M2024-08-30: 4.9M2024-09-13: 5.2M2024-09-30: 5.6M2024-10-15: 5.7M2024-10-31: 5.6M2024-11-15: 5.1M2024-11-29: 4.7M2024-12-13: 5.1M2024-12-31: 6.3M2025-01-15: 6.6M2025-01-31: 6.2M2025-02-14: 6.5M2025-02-28: 8.7M
    the 28 Feb 2025 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 11 Mar 2025Insiders change

    had 4 insiders buy $644K of its shares on the open market within 30 days (4 filings).

    Who bought: Murray Mark Christopher, Sutton Scott McDougald, Kissire Deborah J., Moorthy Ganesh.

    See the evidence (4 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $644K
    Window
    9 Feb 2025 to 11 Mar 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  30. 11 Mar 2025Insiders record

    MOORTHY GANESH (director) bought 1,000 shares of CE ($54,670) (dated 10 Mar 2025)

  31. 11 Mar 2025Insiders record

    Kissire Deborah J. (director) bought 1,000 shares of CE ($54,280) (dated 10 Mar 2025)

  32. 11 Mar 2025Insiders record

    Sutton Scott McDougald (director) bought 7,450 shares of CE ($407,142) (dated 10 Mar 2025)

  33. 11 Mar 2025Insiders record

    Murray Mark Christopher (SVP - Acetyls) bought 2,353 shares of CE ($128,121) (dated 10 Mar 2025)

  34. 14 Feb 2025Filings record

    Director or officer change

  35. 16 Jan 2025Filings record

    Director or officer change

  36. 19 Dec 2024Filings record

    Director or officer change

  37. 12 Dec 2024Filings record

    Director or officer change

  38. 9 Dec 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 9 Dec 2024Filings record

    Director or officer change

  40. 6 Sep 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

Showing the newest 40 of 143 entries; narrow the window or the kind of data to see older ones.

Not listed: 169 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001306830
Ticker
CE
Domain
celanese.com
Employer name
Celanese Corporation, celanese international, Celanese Polymer Products, LLC, Celanese Polymer Products, LLC (f/k/a Dupont Polymer Products, LLC) (4 unverified)
Fein
87-3594684 (1 unverified)
Hq location
TX|IRVING|75039 (1 unverified)
Lobbying client
celanese
Name
Acetate Belgium Holdings B.V, Acetate Europe Coöperatief U.A, Acetate Holdings LLC, Acetate Hong Kong Holdings LLC and 231 more
Wikidata
Q547450
Wikipedia
Celanese
  • DOL H-1B labor condition applications and PERM certifications336 data points25 Nov 2019 to 24 Aug 2026
  • Federal lobbying disclosures (LDA)10 records, 278 data points30 Jun 1999 to 30 Sep 2026
  • SEC Form 13F institutional holdings3 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)197 records21 Jan 2016 to 16 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1325 data points31 Dec 2006 to 30 Oct 2026
  • SEC Form 4 insider transactions49 records, 156 data points4 Mar 2016 to 17 Aug 2026
  • FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • WARN layoff notices (state labor agencies)2 records, 6 data points28 Jan 2008 to 24 Sep 2015
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026